Anti-angiogenesis boosts chemo-immunotherapy in patients with EGFR mutations or baseline liver metastases: insights from IMpower150 study

Detalles Bibliográficos
Autores principales: Rebuzzi, Sara Elena, Facchinetti, Francesco, Tiseo, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797678/
https://www.ncbi.nlm.nih.gov/pubmed/35117143
http://dx.doi.org/10.21037/tcr.2019.06.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797678/
https://www.ncbi.nlm.nih.gov/pubmed/35117143
http://dx.doi.org/10.21037/tcr.2019.06.21

Ejemplares similares